Showing results (141-150 of 427) with videos related to
Sort By:
Pageof 43
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous systemJ L Croxford, M Feldmann, Y Chernajovsky, et al.Annals of the Rheumatic Diseases|October 29, 2000
Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor productionB M Foxwell, J Bondeson, F Brennan, et al.Der Anaesthesist|January 1, 1992
[Droperidol versus metoclopramide. Prevention of emesis following strabismus surgery in children]A Klockgether-Radke, M Feldmann, U Braun, et al.Angiology|July 1, 1995
Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocolsR M Fleming, C H Rose, K M FeldmannCytokine|July 1, 1992
Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytesR Sadeghi, C M Hawrylowicz, Y Chernajovsky, et al.The Journal of Biological Chemistry|April 5, 1996
Involvement of the Saccharomyces cerevisiae HDF1 gene in DNA double-strand break repair and recombinationG J Mages, H M Feldmann, E L WinnackerScientific Reports|February 22, 2020
Muscle oxygen dynamics in elite climbers during finger-hang tests at varying intensitiesAndri M Feldmann, Daniel Erlacher, Sandro Pfister, et al.Cytokine|May 1, 1996
Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonistR Neve, M Kissonerghis, J Clark, et al.Nature|December 13, 1984
Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cellsM Londei, J R Lamb, G F Bottazzo, et al.Immunology Today|March 1, 1989
MS: a localized immune disease of the central nervous systemV Calder, S Owen, C Watson, et al.Pageof 43